effect of Hesperidin,Artemisinin- Artemisia annua, Noscapine, N-acetylcysteine, Resveratrol supplements and high dose of vitamin C on treatment, clinical symptoms of non-hospitalization and hospitalization patients with symptomatic COVID-19

Sirjan Faculty of Medical Science0 个研究点目标入组 100 人开始时间: 待定最近更新: 2020年11月30日

适应症

试验速览

暂无简介。

•COVID-19 virus infection by RT-PCR in non-hospitalization and hospitalization patients
•G6PD sufficient in non-hospitalization and hospitalization patients
•Lack of clinical response to routine outpatient treatment in non-hospitalization and hospitalization patients
•Clinical symptoms (fever, cough, myalgia, shortness of breath, digestive problems) in non-hospitalization and hospitalization patients
•Age over 12 years in non-hospitalization and hospitalization patients
•Patient satisfaction in non-hospitalization and hospitalization patients
•Lymphocytes less than 15%, respiratory distress, lung involvement on CT scan, oxygen level less than 93%, unstable vital signs, severe gastrointestinal symptoms and oral intolerance, underlying disease Except for exclusion cases hospitalization patients

•Allergy to oral supplements and high doses of vitamin C
•Reluctance to continue participating in the trial for any reason
•Patients admitted to the intensive care unit (ICU) (patients who have been admitted to the ICU since admission)
•Pregnant and lactating lady
•Patients with seizures
•Dialysis patients

发起方

Sirjan Faculty of Medical Science